IGF2BP1 has been found to target the ETS Variant Transcription Factor 6 (ETV6)/RUNX1 fusion transcript and potentially regulates its stability in acute lymphatic leukemia (ALL) [163]. Here, ETV6 is linked to acute lymphoblastic leukemia.